AGRX
Agile Therapeutics
AGRX
AGRX
Delisted
AGRX was delisted on the 25th of March, 2024.
17 hedge funds and large institutions have $355K invested in Agile Therapeutics in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
17
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$33.2K | |
| 2 | +$30.9K | |
| 3 | +$8.35K | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$17 |
| 5 |
Comerica Bank
Dallas,
Texas
|
+$10 |
Top Sellers
| 1 | -$57.6K | |
| 2 | -$5.17K | |
| 3 | -$1.98K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.25K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$71 |